DEPRESSION-RELATED DISTURBANCES IN MITOGEN-INDUCED LYMPHOCYTE-RESPONSES AND INTERLEUKIN-1-BETA AND SOLUBLE INTERLEUKIN-2 RECEPTOR PRODUCTION

被引:250
作者
MAES, M
BOSMANS, E
SUY, E
VANDERVORST, C
DEJONCKHEERE, C
RAUS, J
机构
[1] PSYCHIAT CTR WEYBURN,MUNSTERBILZEN,GERMANY
[2] UNIV DIEPENBEEK,DR WILLEMS INST,DIEPENBEEK,BELGIUM
关键词
DEPRESSION; INTERLEUKIN; BLAST TRANSFORMATION; DEXAMETHASONE;
D O I
10.1111/j.1600-0447.1991.tb03163.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In an attempt to delineate the pathophysiology underpinning the previously reported blunted lymphocyte responses to mitogenic stimulation in depressed patients, we measured the following immune variables in 28 depressives and 10 healthy controls: pre- and postdexamethasone (1 mg orally) lymphocyte responses to various mitogens, such as phytohaemagglutinin (PHA), and the PHA-induced accumulation of interleukin-1-beta (Il-1-beta) and soluble interleukin-2-receptors (sIl-2Rs) in culture supernatants. In the predexamethasone state, we found significantly more mitogen-stimulated blastogenesis in minor depressives vs healthy controls and major depressives. In depressed subjects there was a significant inverse relationship between the severity of illness and the mitogen-induced lymphocyte responses. Melancholics exhibited significantly more Il-1-beta accumulation in PHA culture supernatant than healthy controls. In healthy controls - but not in depressed patients - the sIl-2R accumulation perfectly reflects the magnitude of the PHA-induced lymphocyte stimulation. Dexamethasone administration significantly suppressed the lectin-induced blastogenesis and the Il-1-beta production rate in normal volunteers, whereas depressives exhibited dexamethasone nonsuppression in those factors. Healthy controls exhibited significantly less postdexamethasone blast transformation, Il-1-beta and sIl-2Rs accumulation in culture supernatant than the depressed patients.
引用
收藏
页码:379 / 386
页数:8
相关论文
共 59 条
[1]   A CONTROLLED-STUDY OF CELLULAR IMMUNE FUNCTION IN AFFECTIVE-DISORDERS BEFORE AND DURING SOMATIC THERAPY [J].
ALBRECHT, J ;
HELDERMAN, JH ;
SCHLESSER, MA ;
RUSH, AJ .
PSYCHIATRY RESEARCH, 1985, 15 (03) :185-193
[2]  
American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd
[3]  
ARYA SK, 1984, J IMMUNOL, V133, P273
[4]  
BETTENS F, 1984, J IMMUNOL, V132, P261
[5]  
BLOEMENA A, 1988, CLIN IMMUNOL IMMUNOP, V48, P380
[6]   CORTICOSTEROIDS AND LYMPHOID-CELLS [J].
CLAMAN, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (08) :388-+
[7]  
DAWOOD FAM, 1989, BRAZ J MED BIOL RES, V22, P1259
[8]  
DURUM SK, 1985, ANNU REV IMMUNOL, V3, P263
[9]  
FAUCI AS, 1975, BLOOD, V46, P235
[10]   POTENTIATION OF T-LYMPHOCYTE RESPONSE TO MITOGENS .1. RESPONDING CELL [J].
GERY, I ;
GERSHON, RK ;
WAKSMAN, BH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (01) :128-&